What is the best way to describe an Actinic Keratosis (AK)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Actinic Keratosis: Clinical Description and Characteristics

Actinic keratoses (AKs) are keratotic lesions occurring on chronically light-exposed adult skin that represent focal areas of abnormal keratinocyte proliferation and differentiation with a low risk of progression to invasive squamous cell carcinoma (SCC). 1

Definition and Key Features

  • Clinical appearance:

    • Rough, scaly patches or papules on an erythematous base
    • Often better identified by palpation (rough texture) than by visual inspection in early stages
    • Typically 2-10mm in size
    • May be discrete or confluent
  • Histological characteristics:

    • Cardinal feature is epithelial dysplasia
    • Dysplasia may be restricted to the basal layer or extend to full-thickness atypia
    • Disorderly arrangement and maturation of epithelial cells
    • Multiple buds of epithelial cells may occur at the membrane zone without invasion 1
  • Histological variants include:

    • Hypertrophic
    • Bowenoid
    • Lichenoid
    • Acantholytic
    • Pigmented 1

Epidemiology and Risk Factors

  • Primary cause: Chronic exposure to ultraviolet (UV) radiation 1

    • UVB-specific p53 mutations have been demonstrated in AKs 1
  • Prevalence:

    • 19-24% of individuals aged >60 years in UK studies
    • 36% of men aged 40-49 years
    • 49% of men and 28% of women by age 72 in Dutch studies 1
  • Risk factors:

    • Fair skin (Fitzpatrick phototypes I and II)
    • Chronic immunosuppression (organ transplant recipients, inflammatory bowel disease, rheumatological disease)
    • Arsenic exposure
    • Chronic sunbed use 1
    • Older age (linear increase with age from 60-80 years, especially in men) 1

Natural History

  • Chronic disease pattern:

    • Lesions may regress and relapse over time (25-70% apparent resolution over 1-4 years)
    • Single lesion is a marker of excessive sun exposure and associated with development of further lesions 1
  • Malignant transformation:

    • Low rate: less than one in 1000 AKs developing into SCC per annum
    • Risk increases with time: 0.6% of patients developed SCC in AK field within first year, rising to 2.57% at 4 years 1

Distribution and Location

  • Common sites:
    • Head and neck (70% of lesions)
    • Dorsa of hands
    • Other chronically sun-exposed areas 1

Clinical Significance

  • AKs represent a marker of excessive UV exposure and increased risk for developing skin cancer
  • The presence of multiple AKs constitutes a "field cancerization" effect
  • While individual lesion risk of progression to SCC is low, patients with multiple lesions have higher cumulative risk 1

Distinguishing Features

  • AKs differ from SCC in situ (Bowen disease) primarily by the extent of dysplasia
  • When dysplasia extends to full-thickness atypia, the lesion is classified as SCC in situ 1
  • Palpable rough surface often precedes visible lesion 2

Understanding these characteristics is essential for proper identification, risk assessment, and management of actinic keratoses. Early recognition and appropriate treatment can prevent progression to invasive squamous cell carcinoma.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Actinic Keratosis].

Laryngo- rhino- otologie, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.